Source: Health Products Regulatory Authority (IE) Revision Year: 2022 Publisher: Pharma Nord ApS, Tinglykke 4-6, DK-6500 Vojens, Denmark
Ginkgo-Biloba Pharma Nord film-coated tablets.
| Pharmaceutical Form |
|---|
|
Film coated tablet (tablet). White, round (12 mm diameter), biconvex film coated tablet. |
Each tablet contains 100 mg of extract (as dry extract, refined) from Ginkgo biloba L., folium (Ginkgo leaf) (35-67:1), corresponding to:
22.0-27.0 mg of flavonoids expressed as flavone glycosides
2.8-3.4 mg of ginkgolides A, B and C
2.6-3.2 mg of bilobalide.
First extraction solvent: acetone 60% w/w
For full list of excipients see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Ginkgo biloba |
The exact mechanism of action of ginkgo biloba is not known. Human pharmacological data show increased EEG vigilance in geriatric subjects, reduction in blood viscosity and improved cerebral perfusion in specific areas in healthy men (60-70 years) and reduction in platelet aggregation. Additionally, vasodilating effects on forearm blood vessels causing increased regional blood flow are shown. |
| List of Excipients |
|---|
|
Tablet core: Microcrystalline cellulose Film coating: Hypromellose |
PVC/PVDC blisters with aluminium foil backing in a cardboard carton.
Each pack contains 60 or 150 tablets in 30 tablet blister trays.
Not all packs sizes may be marketed.
Pharma Nord ApS, Tinglykke 4-6, DK-6500 Vojens, Denmark
TR1242/001/001
Date of First Registration: 16th March 2018
Date of last renewal: 15th March 2023
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
